Put Options Transactions Made in Q2 2022 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q2 2022. The information is specifically focused on institutions that hold put options of Celldex Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
Eco R1 Capital, LLC
San Francisco, CA |
BUY
|
PUT |
115KNew |
$2.36M - $4.3M
|
115K
$2.97M
|
|
|
Sep 21, 2023
Q2 2022
|
Jefferies Group LLC
New York, NY |
BUY
|
PUT |
108K+ 671.88% |
$2.2M - $4.01M
|
124K
$3.19M
|
|
|
Aug 15, 2022
Q2 2022
|
Jefferies Group LLC
New York, NY |
BUY
|
PUT |
108K+ 671.88% |
$2.2M - $4.01M
|
124K
$3.19M
|
|
|
Nov 08, 2023
Q2 2022
|
Eversept Partners, LP
New York, NY |
BUY
|
PUT |
60.6KNew |
$1.24M - $2.26M
|
60.6K
$1.56M
|
|
|
Aug 15, 2022
Q2 2022
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
PUT |
37.4K+ 32.86% |
$767K - $1.4M
|
151K
$3.9M
|
|
|
Jul 25, 2022
Q2 2022
|
Silverarc Capital Management, LLC
|
BUY
|
PUT |
36KNew |
$738K - $1.34M
|
36K
$928K
|
|
|
Aug 12, 2022
Q2 2022
|
Dld Asset Management, LP
New York, NY |
BUY
|
PUT |
36KNew |
$738K - $1.34M
|
36K
$928K
|
|
|
Aug 15, 2022
Q2 2022
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
PUT |
21.8K+ 33.18% |
$447K - $814K
|
87.5K
$2.26M
|
|
|
Aug 12, 2022
Q2 2022
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
PUT |
21.2K+ 3.56% |
$435K - $791K
|
617K
$15.9M
|
|
|
Aug 15, 2022
Q2 2022
|
Sg3 Management, LLC
Dorado, PR |
BUY
|
PUT |
14K+ 350.0% |
$287K - $523K
|
18K
$464K
|
|
|
Aug 10, 2022
Q2 2022
|
Citigroup Inc
|
BUY
|
PUT |
10KNew |
$205K - $373K
|
10K
$258K
|
|
|
Aug 15, 2022
Q2 2022
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
PUT |
6.3K+ 59.43% |
$129K - $235K
|
16.9K
$436K
|
|
|
Aug 04, 2022
Q2 2022
|
Cutler Group LP
|
BUY
|
PUT |
500+ 14.71% |
$10.3K - $18.7K
|
3.9K
$101K
|
|
|
Aug 08, 2022
Q2 2022
|
Walleye Trading LLC
Plymouth, MN |
SELL
|
PUT |
-17.8K- 66.67% |
$365K - $664K
|
8.9K
$230K
|